AsiaMedic
To make an appointment, call: (65) 6789 8888

Email This Print ThisInsider Trades

Insider Trades Filter

Buyer/Seller : 

Year :         Type :      

Announce Date [Date of Effective Change] Buyer/ Seller Name [Type*] S/ W/ U ** Bought/ (Sold) ('000) Price ($) After Trade Note
No. of Shares ('000) *** % Held ***
29/06/16 [28/06/16] Hong Hai [DIR] R/O/W 150  - NA NA Note
Remarks
Acceptance of employee share options/share awards Immediately after the transaction
No. of rights/options/warrants held: 150,000 No. of shares/units underlying the rights/options/warrants: 150,000
On 28 June 2016, Dr Hong accepted 150,000 share options granted to him on 15 June 2016 under the AsiaMedic Employee Share Option Scheme 2016.
22/06/16 [22/06/16] GOH KIAN CHEE [DIR] R/O/W 150  - NA NA Note
Remarks
Acceptance of employee share options/share awards Immediately after the transaction
No. of rights/options/warrants held: 150,000 No. of shares/units underlying the rights/options/warrants: 150,000
On 22 June 2016, Mr Goh accepted 150,000 share options granted to him on 15 June 2016 under the AsiaMedic Employee Share Option Scheme 2016.
14/03/16 [11/03/16] Guo Wenfei [DIR] S/U 2,000  - 2,000 0.51 Note
Remarks
Acquisition of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): S$132,000 Immediately after the transaction
No. of ordinary voting shares/units held: 2000000 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.51200000 (Direct Interest); 0.00000000 (Deemed Interest)
14/03/16 [11/03/16] Koh Boon How [DIR] S/U (1,000)  - 1,500 0.38 Note
Remarks
Disposal of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): S$66,000 Immediately after the transaction
No. of ordinary voting shares/units held: 1500000 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.38400000 (Direct Interest); 0.00000000 (Deemed Interest)
14/03/16 [11/03/16] Tan Soo Kiat [DIR] S/U (1,000)  - 8,000 2.05 Note
Remarks
Disposal of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): S$66,000 Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 8000000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 2.04900000 (Deemed Interest)
Deemed interest represents shares in a nominee account.
21/01/16 [21/01/16] Koh Boon How [DIR] S/U 2,500  - 2,500 0.64 Note
Remarks
Acquisition of Securities via a placement Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): S$137,500 Immediately after the transaction
No. of ordinary voting shares/units held: 2500000 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.64000000 (Direct Interest); 0.00000000 (Deemed Interest)
21/01/16 [21/01/16] Tan Soo Kiat [DIR] S/U 9,000  - 9,000 2.30 Note
Remarks
Acquisition of Securities via a placement Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): S$495,000.00 Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 9000000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 2.30000000 (Deemed Interest)
Deemed interest represents shares in a nominee account.
03/06/15 [03/06/15] ALINA W LIU [SSH] S/U 95,431  - 95,431 28.15 Note
Remarks
Acquisition of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$17,177,651.28 Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 95431396 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 28.15000000 (Deemed Interest)
Alina W Liu is one of the beneficiaries under The Asoka Trust. Accordingly, Alia W Liu is deemed to be interested in the AML Shares that The Asoka Trust has an interest in. Luye Medicals Group Pte. Ltd. holds the 95,431,396 AML Shares directly. Luye Medicals Investment Pte. Ltd. holds 100% of the issued and paid up share capital of Luye Medicals Group Pte. Ltd. and is deemed interested in the AML Shares that Luye Medicals Group Pte. Ltd. has an interest in. Luye Group Ltd holds 100% of the issued and paid up share capital of Luye Medicals Investment Pte. Ltd. and is deemed to be interested in the AML Shares that Luye Medicals Investment Pte. Ltd. has an interest in. Nelumbo Investments Limited holds 70% of the issued and paid up share capital of Luye Group Ltd and is deemed to be interested in the AML Shares that Luye Group Ltd has an interest in. The shares representing 100% of the issued and paid up share capital of Nelumbo Investments Limited are held as trust property of The Asoka Trust. Accordingly, The Asoka Trust is deemed interested in the AML Shares that Nelumbo Investments Limited has an interest in. Liu Dianbo, Wang Cuilian, Aona Liu and Alina W Liu are the beneficiaries under The Asoka Trust and deemed to be interested in the AML Shares that The Asoka Trust has an interest in. The percentage of shareholding is calculated based on 338,988,125 issued and paid up shares in the capital of Asiamedic Limited (excluding treasury shares).
03/06/15 [03/06/15] AONA LIU [SSH] S/U 95,431  - 95,431 28.15 Note
Remarks
Acquisition of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$17,177,651.28 Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 95431396 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 28.15000000 (Deemed Interest)
Aona Liu is one of the beneficiaries under The Asoka Trust. Accordingly, Aona Liu is deemed to be interested in the AML Shares that The Asoka Trust has an interest in. Luye Medicals Group Pte. Ltd. holds the 95,431,396 AML Shares directly. Luye Medicals Investment Pte. Ltd. holds 100% of the issued and paid up share capital of Luye Medicals Group Pte. Ltd. and is deemed interested in the AML Shares that Luye Medicals Group Pte. Ltd. has an interest in. Luye Group Ltd holds 100% of the issued and paid up share capital of Luye Medicals Investment Pte. Ltd. and is deemed to be interested in the AML Shares that Luye Medicals Investment Pte. Ltd. has an interest in. Nelumbo Investments Limited holds 70% of the issued and paid up share capital of Luye Group Ltd and is deemed to be interested in the AML Shares that Luye Group Ltd has an interest in. The shares representing 100% of the issued and paid up share capital of Nelumbo Investments Limited are held as trust property of The Asoka Trust. Accordingly, The Asoka Trust is deemed interested in the AML Shares that Nelumbo Investments Limited has an interest in. Liu Dianbo, Wang Cuilian, Aona Liu and Alina W Liu are the beneficiaries under The Asoka Trust and deemed to be interested in the AML Shares that The Asoka Trust has an interest in. The percentage of shareholding is calculated based on 338,988,125 issued and paid up shares in the capital of Asiamedic Limited (excluding treasury shares).
03/06/15 [03/06/15] LIU DIANBO [SSH] S/U 95,431  - 95,431 28.15 Note
Remarks
Acquisition of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$17,177,651.28 Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 95431396 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 28.15000000 (Deemed Interest)
Liu Dianbo is one of the beneficiaries under The Asoka Trust. Accordingly, Liu Dianbo is deemed to be interested in the AML Shares that The Asoka Trust has an interest in. Luye Medicals Group Pte. Ltd. holds the 95,431,396 AML Shares directly. Luye Medicals Investment Pte. Ltd. holds 100% of the issued and paid up share capital of Luye Medicals Group Pte. Ltd. and is deemed interested in the AML Shares that Luye Medicals Group Pte. Ltd. has an interest in. Luye Group Ltd holds 100% of the issued and paid up share capital of Luye Medicals Investment Pte. Ltd. and is deemed to be interested in the AML Shares that Luye Medicals Investment Pte. Ltd. has an interest in. Nelumbo Investments Limited holds 70% of the issued and paid up share capital of Luye Group Ltd and is deemed to be interested in the AML Shares that Luye Group Ltd has an interest in. The shares representing 100% of the issued and paid up share capital of Nelumbo Investments Limited are held as trust property of The Asoka Trust. Accordingly, The Asoka Trust is deemed interested in the AML Shares that Nelumbo Investments Limited has an interest in. Liu Dianbo, Wang Cuilian, Aona Liu and Alina W Liu are the beneficiaries under The Asoka Trust and deemed to be interested in the AML Shares that The Asoka Trust has an interest in. The percentage of shareholding is calculated based on 338,988,125 issued and paid up shares in the capital of Asiamedic Limited (excluding treasury shares).
03/06/15 [03/06/15] LUYE GROUP LTD [SSH] S/U 95,431  - 95,431 28.15 Note
Remarks
Acquisition of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$17,177,651.28 Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 95431396 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 28.15000000 (Deemed Interest)
Luye Group Ltd holds 100% of the issued and paid up share capital of Luye Medicals Investment Pte. Ltd. and is deemed to be interested in the AML Shares that Luye Medicals Investment Pte. Ltd. has an interest in. Luye Medicals Group Pte. Ltd. holds the 95,431,396 AML Shares directly. Luye Medicals Investment Pte. Ltd. holds 100% of the issued and paid up share capital of Luye Medicals Group Pte. Ltd. and is deemed interested in the AML Shares that Luye Medicals Group Pte. Ltd. has an interest in. Luye Group Ltd holds 100% of the issued and paid up share capital of Luye Medicals Investment Pte. Ltd. and is deemed to be interested in the AML Shares that Luye Medicals Investment Pte. Ltd. has an interest in. Nelumbo Investments Limited holds 70% of the issued and paid up share capital of Luye Group Ltd and is deemed to be interested in the AML Shares that Luye Group Ltd has an interest in. The shares representing 100% of the issued and paid up share capital of Nelumbo Investments Limited are held as trust property of The Asoka Trust. Accordingly, The Asoka Trust is deemed interested in the AML Shares that Nelumbo Investments Limited has an interest in. Liu Dianbo, Wang Cuilian, Aona Liu and Alina W Liu are the beneficiaries under The Asoka Trust and deemed to be interested in the AML Shares that The Asoka Trust has an interest in. The percentage of shareholding is calculated based on 338,988,125 issued and paid up shares in the capital of Asiamedic Limited (excluding treasury shares).
03/06/15 [03/06/15] LUYE MEDICALS GROUP PTE. LTD. [SSH] S/U 95,431  - 95,431 28.15 Note
Remarks
Acquisition of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$17,177,651.28 Immediately after the transaction
No. of ordinary voting shares/units held: 95431396 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 28.15000000 (Direct Interest); 0.00000000 (Deemed Interest)
Luye Medicals Group Pte. Ltd. holds the 95,431,396 shares in Asiamedic Limited ("AML Shares") directly. Luye Medicals Investment Pte. Ltd. holds 100% of the issued and paid up share capital of Luye Medicals Group Pte. Ltd. and is deemed interested in the AML Shares that Luye Medicals Group Pte. Ltd. has an interest in. Luye Group Ltd holds 100% of the issued and paid up share capital of Luye Medicals Investment Pte. Ltd. and is deemed to be interested in the AML Shares that Luye Medicals Investment Pte. Ltd. has an interest in. Nelumbo Investments Limited holds 70% of the issued and paid up share capital of Luye Group Ltd and is deemed to be interested in the AML Shares that Luye Group Ltd has an interest in. The shares representing 100% of the issued and paid up share capital of Nelumbo Investments Limited are held as trust property of The Asoka Trust. Accordingly, The Asoka Trust is deemed interested in the AML Shares that Nelumbo Investments Limited has an interest in. Liu Dianbo, Wang Cuilian, Aona Liu and Alina W Liu are the beneficiaries under The Asoka Trust and deemed to be interested in the AML Shares that The Asoka Trust has an interest in. The percentage of shareholding is calculated based on 338,988,125 issued and paid up shares in the capital of Asiamedic Limited (excluding treasury shares).
03/06/15 [03/06/15] LUYE MEDICALS INVESTMENT PTE. LTD. [SSH] S/U 95,431  - 95,431 28.15 Note
Remarks
Acquisition of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$17,177,651.28 Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 95431396 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 28.15000000 (Deemed Interest)
Luye Medicals Investment Pte. Ltd. holds 100% of the issued and paid up share capital of Luye Medicals Group Pte. Ltd. and is deemed interested in the AML Shares that Luye Medicals Group Pte. Ltd. has an interest in. Luye Medicals Group Pte. Ltd. holds the 95,431,396 AML Shares directly. Luye Medicals Investment Pte. Ltd. holds 100% of the issued and paid up share capital of Luye Medicals Group Pte. Ltd. and is deemed interested in the AML Shares that Luye Medicals Group Pte. Ltd. has an interest in. Luye Group Ltd holds 100% of the issued and paid up share capital of Luye Medicals Investment Pte. Ltd. and is deemed to be interested in the AML Shares that Luye Medicals Investment Pte. Ltd. has an interest in. Nelumbo Investments Limited holds 70% of the issued and paid up share capital of Luye Group Ltd and is deemed to be interested in the AML Shares that Luye Group Ltd has an interest in. The shares representing 100% of the issued and paid up share capital of Nelumbo Investments Limited are held as trust property of The Asoka Trust. Accordingly, The Asoka Trust is deemed interested in the AML Shares that Nelumbo Investments Limited has an interest in. Liu Dianbo, Wang Cuilian, Aona Liu and Alina W Liu are the beneficiaries under The Asoka Trust and deemed to be interested in the AML Shares that The Asoka Trust has an interest in. The percentage of shareholding is calculated based on 338,988,125 issued and paid up shares in the capital of Asiamedic Limited (excluding treasury shares).
03/06/15 [03/06/15] NELUMBO INVESTMENTS LIMITED [SSH] S/U 95,431  - 95,431 28.15 Note
Remarks
Acquisition of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$17,177,651.28 Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 95431396 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 28.15000000 (Deemed Interest)
Nelumbo Investments Limited holds 70% of the issued and paid up share capital of Luye Group Ltd and is deemed to be interested in the AML Shares that Luye Group Ltd has an interest in. Luye Medicals Group Pte. Ltd. holds the 95,431,396 AML Shares directly. Luye Medicals Investment Pte. Ltd. holds 100% of the issued and paid up share capital of Luye Medicals Group Pte. Ltd. and is deemed interested in the AML Shares that Luye Medicals Group Pte. Ltd. has an interest in. Luye Group Ltd holds 100% of the issued and paid up share capital of Luye Medicals Investment Pte. Ltd. and is deemed to be interested in the AML Shares that Luye Medicals Investment Pte. Ltd. has an interest in. Nelumbo Investments Limited holds 70% of the issued and paid up share capital of Luye Group Ltd and is deemed to be interested in the AML Shares that Luye Group Ltd has an interest in. The shares representing 100% of the issued and paid up share capital of Nelumbo Investments Limited are held as trust property of The Asoka Trust. Accordingly, The Asoka Trust is deemed interested in the AML Shares that Nelumbo Investments Limited has an interest in. Liu Dianbo, Wang Cuilian, Aona Liu and Alina W Liu are the beneficiaries under The Asoka Trust and deemed to be interested in the AML Shares that The Asoka Trust has an interest in. The percentage of shareholding is calculated based on 338,988,125 issued and paid up shares in the capital of Asiamedic Limited (excluding treasury shares).
03/06/15 [03/06/15] THE ASOKA TRUST [SSH] S/U 95,431  - 95,431 28.15 Note
Remarks
Acquisition of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$17,177,651.28 Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 95431396 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 28.15000000 (Deemed Interest)
The shares representing 100% of the issued and paid up share capital of Nelumbo Investments Limited are held as trust property of The Asoka Trust. Accordingly, The Asoka Trust is deemed interested in the AML Shares that Nelumbo Investments Limited has an interest in. Luye Medicals Group Pte. Ltd. holds the 95,431,396 AML Shares directly. Luye Medicals Investment Pte. Ltd. holds 100% of the issued and paid up share capital of Luye Medicals Group Pte. Ltd. and is deemed interested in the AML Shares that Luye Medicals Group Pte. Ltd. has an interest in. Luye Group Ltd holds 100% of the issued and paid up share capital of Luye Medicals Investment Pte. Ltd. and is deemed to be interested in the AML Shares that Luye Medicals Investment Pte. Ltd. has an interest in. Nelumbo Investments Limited holds 70% of the issued and paid up share capital of Luye Group Ltd and is deemed to be interested in the AML Shares that Luye Group Ltd has an interest in. The shares representing 100% of the issued and paid up share capital of Nelumbo Investments Limited are held as trust property of The Asoka Trust. Accordingly, The Asoka Trust is deemed interested in the AML Shares that Nelumbo Investments Limited has an interest in. Liu Dianbo, Wang Cuilian, Aona Liu and Alina W Liu are the beneficiaries under The Asoka Trust and deemed to be interested in the AML Shares that The Asoka Trust has an interest in. The percentage of shareholding is calculated based on 338,988,125 issued and paid up shares in the capital of Asiamedic Limited (excluding treasury shares).
03/06/15 [03/06/15] WANG CUILIAN [SSH] S/U 95,431  - 95,431 28.15 Note
Remarks
Acquisition of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$17,177,651.28 Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 95431396 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 28.15000000 (Deemed Interest)
Wang Cuilian is one of the beneficiaries under The Asoka Trust. Accordingly, Wang Cuilian is deemed to be interested in the AML Shares that The Asoka Trust has an interest in. Luye Medicals Group Pte. Ltd. holds the 95,431,396 AML Shares directly. Luye Medicals Investment Pte. Ltd. holds 100% of the issued and paid up share capital of Luye Medicals Group Pte. Ltd. and is deemed interested in the AML Shares that Luye Medicals Group Pte. Ltd. has an interest in. Luye Group Ltd holds 100% of the issued and paid up share capital of Luye Medicals Investment Pte. Ltd. and is deemed to be interested in the AML Shares that Luye Medicals Investment Pte. Ltd. has an interest in. Nelumbo Investments Limited holds 70% of the issued and paid up share capital of Luye Group Ltd and is deemed to be interested in the AML Shares that Luye Group Ltd has an interest in. The shares representing 100% of the issued and paid up share capital of Nelumbo Investments Limited are held as trust property of The Asoka Trust. Accordingly, The Asoka Trust is deemed interested in the AML Shares that Nelumbo Investments Limited has an interest in. Liu Dianbo, Wang Cuilian, Aona Liu and Alina W Liu are the beneficiaries under The Asoka Trust and deemed to be interested in the AML Shares that The Asoka Trust has an interest in. The percentage of shareholding is calculated based on 338,988,125 issued and paid up shares in the capital of Asiamedic Limited (excluding treasury shares).
03/06/15 [03/06/15] Tan Guek Ming [SSH] S/U (14,091)  - 8,468 2.50 Note
Remarks
Disposal of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$2,536,451.28 Immediately after the transaction
No. of ordinary voting shares/units held: 8467598 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 2.50000000 (Direct Interest); 0.00000000 (Deemed Interest)
Deemed interest represents shares held by her spouse, Mr Tan Wang Cheow.
03/06/15 [03/06/15] Carrel Investments Ltd [SSH] S/U (81,340)  - NA NA Note
Remarks
Disposal of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$14,641,200 Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 0.00000000 (Deemed Interest)
Carrel Investments Ltd ("Carrel") owns 50% of the issued share capital of Grandiflora Pte Ltd ("Grandiflora"). Accordingly, Carrel is deemed interested in the shares held by Grandiflora. Carrel Investments Ltd ("Carrel") owns 50% of the issued share capital of Grandiflora Pte Ltd. Carrel is wholly-owned by Colink Assets Holding Limited ("Colink"). Colink is wholly-owned by Mr Chairul Tanjung Gafar.
03/06/15 [03/06/15] Chairul Tanjung Gafar [SSH] S/U (81,340)  - NA NA Note
Remarks
Disposal of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$14,641,200 Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 0.00000000 (Deemed Interest)
Carrel Investments Ltd ("Carrel") owns 50% of the issued share capital of Grandiflora Pte Ltd ("Grandiflora"). Carrel is wholly-owned by Colink Assets Holding Limited ("Colink"). Colink is wholly-owned by Mr Chairul Tanjung Gafar. Accordingly, Mr Chairul Tanjung Gafar is deemed interested in the shares held by Grandiflora. Carrel Investments Ltd ("Carrel") owns 50% of the issued share capital of Grandiflora Pte Ltd. Carrel is wholly-owned by Colink Assets Holding Limited ("Colink"). Colink is wholly-owned by Mr Chairul Tanjung Gafar.
03/06/15 [03/06/15] Colink Assets Holding Limited [SSH] S/U (81,340)  - NA NA Note
Remarks
Disposal of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$14,641,200 Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 0.00000000 (Deemed Interest)
Carrel Investments Ltd ("Carrel") owns 50% of the issued share capital of Grandiflora Pte Ltd ("Grandiflora"). Carrel is wholly-owned by Colink Assets Holding Limited ("Colink"). Accordingly, Colink is deemed interested in the shares held by Grandiflora. Carrel Investments Ltd ("Carrel") owns 50% of the issued share capital of Grandiflora Pte Ltd. Carrel is wholly-owned by Colink Assets Holding Limited ("Colink"). Colink is wholly-owned by Mr Chairul Tanjung Gafar.
03/06/15 [03/06/15] Grandiflora Pte Ltd [SSH] S/U (81,340)  - NA NA Note
Remarks
Disposal of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$14,641,200 Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 0.00000000 (Deemed Interest)
Carrel Investments Ltd ("Carrel") owns 50% of the issued share capital of Grandiflora Pte Ltd. Carrel is wholly-owned by Colink Assets Holding Limited ("Colink"). Colink is wholly-owned by Mr Chairul Tanjung Gafar.
03/06/15 [03/06/15] Grandiflora Pte Ltd [SSH] S/U (81,340)  - NA NA Note
Remarks
Disposal of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$14,641,200 Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 0.00000000 (Deemed Interest)
Skion Holdings Ltd ("Skion") owns 50% of the issued share capital of Grandiflora Pte Ltd. Skion is wholly-owned by Mr Anthoni Salim.
03/06/15 [03/06/15] Mr Anthoni Salim [SSH] S/U (81,340)  - NA NA Note
Remarks
Disposal of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$14,641,200 Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 0.00000000 (Deemed Interest)
Skion Holdings Ltd ("Skion") owns 50% of the issued share capital of Grandiflora Pte Ltd ("Grandiflora"). Skion is wholly-owned by Mr Anthoni Salim. Accordingly, Mr Anthoni Salim is deemed interested in the shares held by Grandiflora. Skion Holdings Ltd ("Skion") owns 50% of the issued share capital of Grandiflora Pte Ltd. Skion is wholly-owned by Mr Anthoni Salim.
03/06/15 [03/06/15] Skion Holdings Ltd [SSH] S/U (81,340)  - NA NA Note
Remarks
Disposal of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$14,641,200 Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 0.00000000 (Deemed Interest)
Skion Holdings Ltd ("Skion") owns 50% of the issued share capital of Grandiflora Pte Ltd ("Grandiflora"). Accordingly, Skion is deemed interested in the shares held by Grandiflora. Skion Holdings Ltd ("Skion") owns 50% of the issued share capital of Grandiflora Pte Ltd. Skion is wholly-owned by Mr Anthoni Salim.
03/06/15 [03/06/15] Tan Wang Cheow [SSH] S/U (14,091)  - 8,468 2.50 Note
Remarks
Disposal of Securities via off-market transaction (e.g. married deals) Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$2,536,451.28 Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 8467598 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 2.50000000 (Deemed Interest)
Deemed interest represents shares held by his spouse, Mdm Tan Guek Ming.
11/12/14 [11/12/14] DR WONG WENG HONG [DIR] S/U 20  - 14,666 4.33 Note
Remarks
Acquisition of Securities via market transaction Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): 1,400.00 Immediately after the transaction
No. of ordinary voting shares/units held: 62000 (Direct Interest); 14604000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.01830000 (Direct Interest); 4.30810000 (Deemed Interest)
Deemed interest represents shares held in nominee accounts.
20/11/14 [20/11/14] DR WONG WENG HONG [DIR] S/U 25  - 14,646 4.32 Note
Remarks
Acquisition of Securities via market transaction Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): 1,885.00 Immediately after the transaction
No. of ordinary voting shares/units held: 42000 (Direct Interest); 14604000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.01240000 (Direct Interest); 4.30810000 (Deemed Interest)
Deemed interest represents shares held in nominee accounts.
14/11/14 [13/11/14] DR WONG WENG HONG [DIR] S/U 5  - 14,621 4.31 Note
Remarks
Acquisition of Securities via market transaction Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): 375.00 Immediately after the transaction
No. of ordinary voting shares/units held: 17000 (Direct Interest); 14604000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00500000 (Direct Interest); 4.30800000 (Deemed Interest)
Deemed interest represents shares held in nominee accounts.
20/10/14 [17/10/14] DR WONG WENG HONG [DIR] S/U 7  - 14,616 4.31 Note
Remarks
Acquisition of Securities via market transaction Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): 546.00 Immediately after the transaction
No. of ordinary voting shares/units held: 12000 (Direct Interest); 14604000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00400000 (Direct Interest); 4.30800000 (Deemed Interest)
Deemed interest represents shares held in nominee accounts.
17/10/14 [16/10/14] DR WONG WENG HONG [DIR] S/U 5  - 14,609 4.31 Note
Remarks
Acquisition of Securities via market transaction Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): 375.00 Immediately after the transaction
No. of ordinary voting shares/units held: 5000 (Direct Interest); 14604000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00200000 (Direct Interest); 4.30800000 (Deemed Interest)
Deemed interest represents shares held in nominee accounts.
24/04/14 [23/04/14] DR WONG WENG HONG [DIR] S/U 20  - 14,604 4.31 Note
Remarks
Acquisition of Securities via market transaction Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): $1,960 Immediately after the transaction
No. of ordinary voting shares/units held: 2204000 (Direct Interest); 12400000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.65000000 (Direct Interest); 3.65800000 (Deemed Interest)
Deemed interest represents shares held in nominee account.
20/01/14 [17/01/14] Dr Wong Weng Hong [DIR] S/U 54  - 14,584 4.30 Note
Remarks
Acquisition of Securities via market transaction Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): S$5,400.00 Immediately after the transaction
No. of ordinary voting shares/units held: 184000 (Direct Interest); 14400000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.05400000 (Direct Interest); 4.24800000 (Deemed Interest)
13/01/14 [10/01/14] Dr Wong Weng Hong [DIR] S/U 30  - 14,530 4.29 Note
Remarks
Acquisition of Securities via market transaction Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): S$2,940.00 Immediately after the transaction
No. of ordinary voting shares/units held: 130000 (Direct Interest); 14400000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.03800000 (Direct Interest); 4.24800000 (Deemed Interest)
10/01/14 [09/01/14] Dr Wong Weng Hong [DIR] S/U 20  - 14,500 4.28 Note
Remarks
Acquisition of Securities via market transaction Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): S$1,900.00 Immediately after the transaction
No. of ordinary voting shares/units held: 100000 (Direct Interest); 14400000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.02900000 (Direct Interest); 4.24800000 (Deemed Interest)
04/01/14 [02/01/14] Dr Wong Weng Hong [DIR] S/U 20  - 14,480 4.27 Note
Remarks
Acquisition of Securities via market transaction Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): S$1,940.00 Immediately after the transaction
No. of ordinary voting shares/units held: 80000 (Direct Interest); 14400000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.02400000 (Direct Interest); 4.24800000 (Deemed Interest)
19/12/13 [17/12/13] Dr Wong Weng Hong [DIR] S/U 60  - 14,460 4.27 Note
Remarks
Acquisition of Securities via market transaction Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): S$5,719.02 Immediately after the transaction
No. of ordinary voting shares/units held: 60000 (Direct Interest); 14400000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.01800000 (Direct Interest); 4.24800000 (Deemed Interest)
14/03/13 [13/03/13] Dr Wong Weng Hong [DIR] S/U 200  - 14,400 4.30 Note
Remarks
Acquisition of Securities via market transaction Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): S$19,800 Immediately after the transaction
No. of ordinary voting shares/units held: 14400000 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 4.30000000 (Direct Interest); 0.00000000 (Deemed Interest)
12/03/13 [11/03/13] Dr Wong Weng Hong [DIR] S/U 115  - 14,200 4.24 Note
Remarks
Acquisition of Securities via market transaction Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): S$11,370 Immediately after the transaction
No. of ordinary voting shares/units held: 14200000 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 4.24000000 (Direct Interest); 0.00000000 (Deemed Interest)
11/03/13 [08/03/13] Dr Wong Weng Hong [DIR] S/U 85  - 14,085 4.20 Note
Remarks
Acquisition of Securities via market transaction Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): S$9,520 Immediately after the transaction
No. of ordinary voting shares/units held: 14085000 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 4.20000000 (Direct Interest); 0.00000000 (Deemed Interest)
06/03/13 [05/03/13] Dr Wong Weng Hong [DIR] S/U 100  - 13,600 4.10 Note
Remarks
Acquisition of Securities via market transaction Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): S$11,800 Immediately after the transaction
No. of ordinary voting shares/units held: 13600000 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 4.10000000 (Direct Interest); 0.00000000 (Deemed Interest)
06/03/13 [06/03/13] Dr Wong Weng Hong [DIR] S/U 400  - 14,000 4.20 Note
Remarks
Acquisition of Securities via market transaction Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): S$48,400 Immediately after the transaction
No. of ordinary voting shares/units held: 14000000 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 4.20000000 (Direct Interest); 0.00000000 (Deemed Interest)
05/03/13 [04/03/13] Dr Wong Weng Hong [DIR] S/U 100  - 13,500 4.00 Note
Remarks
Acquisition of Securities via market transaction Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): S$12,100 Immediately after the transaction
No. of ordinary voting shares/units held: 13500000 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 4.00000000 (Direct Interest); 0.00000000 (Deemed Interest)
04/03/13 [01/03/13] Dr Wong Weng Hong [DIR] S/U 400  - 13,400 4.00 Note
Remarks
Acquisition of Securities via market transaction Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): S$50,300 Immediately after the transaction
No. of ordinary voting shares/units held: 13400000 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 4.00000000 (Direct Interest); 0.00000000 (Deemed Interest)
13/06/12 [13/06/12] ASIAMEDIC LIMITED [COY] S 50  0.028-0.031 NA NA Note
Remarks
This announcement has been prepared by the Company and reviewed by the Company's sponsor, Asiasons WFG Capital Pte Ltd (the "Sponsor"), for compliance with the Listing Manual (Section B: Rules of Catalist) of the Singapore Exchange Securities Trading Limited (the "SGX-ST"). The Sponsor has not independently verified the contents of this announcement including the accuracy or completeness of any of the information disclosed or the correctness of any of the statements made, opinions expressed or reports contained in this announcement. This announcement has not been examined or approved by the SGX-ST. The SGX-ST and the Sponsor assume no responsibility for the contents of this announcement including the correctness of any of the statements made, opinions expressed or reports contained in this announcement. Contact person for the Sponsor: Ms Pauline Sim (Registered Professional, Asiasons WFG Capital Pte Ltd) Address: 70 Anson Road, 24-01 Hub Synergy Point, Singapore 079905 Telephone number: (65) 6319 4954
16/12/11 [15/12/11] ASIAMEDIC LIMITED [COY] S 50  0.025 NA NA Note
Remarks
This announcement has been prepared by the Company and reviewed by the Company's sponsor, Asiasons WFG Capital Pte Ltd (the "Sponsor"), for compliance with the Listing Manual (Section B: Rules of Catalist) of the Singapore Exchange Securities Trading Limited (the "SGX-ST"). The Sponsor has not independently verified the contents of this announcement including the accuracy or completeness of any of the information disclosed or the correctness of any of the statements made, opinions expressed or reports contained in this announcement. This announcement has not been examined or approved by the SGX-ST. The SGX-ST and the Sponsor assume no responsibility for the contents of this announcement including the correctness of any of the statements made, opinions expressed or reports contained in this announcement. Contact person for the Sponsor: Ms Pauline Sim (Registered Professional, Asiasons WFG Capital Pte Ltd) Address: 70 Anson Road, 24-01 Hub Synergy Point, Singapore 079905 Telephone number: (65) 6319 4954
24/03/10 [23/03/10] Suzanne Liau [DIR] S 100  0.055 800 0.24 Note
Remarks
The percentage of shareholding before and after the change is calculated based on the issued share capital of 335,325,219 ordinary shares. Ms Suzanne Liau is deemed to be interested in the shares held by her husband. This announcement has been prepared by the Company and the contents have been reviewed by the Company's Sponsor, Phillip Securities Pte Ltd, for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited ("Exchange").The Company's Sponsor has not independently verified the contents of this announcement. This announcement has not been examined or approved by the Exchange and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Ms. Loh Peck Kuan (Director, Corporate Finance), Phillip Securities Pte Ltd, 250 North Bridge Road, 06-00 Raffles City Tower, Singapore 179101, telephone (65) 6533 6001.
24/03/10 [22/03/10] Suzanne Liau [DIR] S 100  0.060 700 0.21 Note
Remarks
The percentage of shareholding before and after the change is calculated based on the issued share capital of 335,325,219 ordinary shares. Ms Suzanne Liau is deemed to be interested in the shares held by her husband. This announcement has been prepared by the Company and the contents have been reviewed by the Company's Sponsor, Phillip Securities Pte Ltd, for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited ("Exchange").The Company's Sponsor has not independently verified the contents of this announcement. This announcement has not been examined or approved by the Exchange and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Ms. Loh Peck Kuan (Director, Corporate Finance), Phillip Securities Pte Ltd, 250 North Bridge Road, 06-00 Raffles City Tower, Singapore 179101, telephone (65) 6533 6001.
21/08/07 [14/08/07] Tan Guek Ming [SSH] S 21,169  0.118 22,559 6.73 Note
Remarks
Subscription of 8,467,598 ordinary shares via share placement exercise whereby a total of 42,337,989 new ordinary shares were issued by Asiamedic Limited (the "Company"). This resulted in the increase in the issued share capital of the Company from 292,987,230 shares to 335,325,219 shares.
21/08/07 [14/08/07] Tan Wang Cheow [SSH] S 21,169  0.118 22,559 6.73 Note
Remarks
Subsciption of 12,701,396 ordinary shares via share placement exercise whereby a total of 42,337,989 new ordinary shares were issued by Asiamedic Limited (the "Company"). This resulted in the increase in the issued share capital of the Company from 292,987,230 shares to 335,325,219 shares.
18/12/06 [01/12/06] Suzanne Liau [DIR] S 500  - 600 0.20 Note
Remarks
From spouse's mother to spouse.
02/09/05 [26/08/05] Anthoni Salim [SSH] S 81,340  0.160 81,340 27.76 Note
Remarks
GRANDIFLORA PTE LTD ENTERED INTO A PUT AND CALL OPTION AGREEMENT WITH BILLIONTEX INTERNATIONAL LIMITED AND SILVER BEADS INTERNATIONAL LIMITED ON 26 AUGUST 2005 UNDER WHICH GRANDIFLORA PTE LTD ACQUIRED A RIGHT TO ACQUIRE SUCH INTEREST CONDITIONAL UPON THE EXERCISE OF EITHER THE PUT OR CALL OPTION. ANTHONI SALIM HAS A DEEMED INTEREST OF 50% SHAREHOLDING IN GRANDIFLORA PTE LTD
02/09/05 [26/08/05] Chairul Tanjung [SSH] S 81,340  0.160 81,340 27.76 Note
Remarks
GRANDIFLORA PTE LTD ENTERED INTO A PUT AND CALL OPTION AGREEMENT WITH BILLIONTEX INTERNATIONAL LIMITED AND SILVER BEADS INTERNATIONAL LIMITED ON 26 AUGUST 2005, UNDER WHICH GRANDIFLORA PTE LTD ACQUIRED A RIGHT TO ACQUIRE SUCH INTEREST CONDITIONAL UPON THE EXERCISE OF EITHER THE PUT OR CALL OPTION. MR CHAIRUL TANJUNG A DEEMED INTEREST OF 50% SHAREHOLDING IN GRANDIFLORA PTE LTD.
01/09/05 [01/09/05] Billiontex International Limited [SSH] S (26,008)  0.160 NA NA Note
Remarks
COMPLETION OF PUT AND CALL OPTION AGREEMENT DATED 26 AUGUST 2005
01/09/05 [01/09/05] Djeng Shih Kien [DIR] S (55,332)  0.160 26,008 8.88 Note
Remarks
COMPLETION OF PUT AND CALL OPTION AGREEMENT DATED 26 AUGUST 2005
01/09/05 [01/09/05] Djeng Shih Kien [DIR] S (26,008)  0.160 NA NA Note
Remarks
COMPLETION OF PUT AND CALL OPTION AGREEMENT DATED 26 AUGUST 2005
01/09/05 [01/09/05] Dominic Er Kong Kiong [DIR] S (55,332)  0.160 27,619 9.42 Note
Remarks
COMPLETION OF PUT AND CALL OPTION AGREEMENT DATED 26 AUGUST 2005
01/09/05 [01/09/05] Dominic Er Kong Kiong [DIR] S (26,008)  0.160 1,611 0.55 Note
Remarks
COMPLETION OF PUT AND CALL OPTION AGREEMENT DATED 26 AUGUST 2005
01/09/05 [01/09/05] Silver Beads International Limited [SSH] S (55,332)  0.160 NA NA Note
Remarks
COMPLETION OF PUT AND CALL OPTION AGREEMENT DATED 26 AUGUST 2005
31/08/05 [30/08/05] Tan Boen Eng [DIR] S (400)  0.135 NA NA -
Remarks
30/08/05 [26/08/05] Grandiflora Pte Ltd [SSH] S (81,340)  0.160 NA NA Note
Remarks
ENTERED INTO A PUT AND CALL OPTION AGREEMENT WITH BILLIONTEX INTERNATIONAL LIMITED AND SILVER BEADS INTERNATIONAL LIMITED ON 26 AUGUST 2005, UNDER WHICH GRANDIFLORA PTE LTD ACQUIRED A RIGHT TO ACQUIRE SUCH INTEREST CONDITIONAL UPON THE EXERCISE OF EITHER THE PUT OR CALL OPTION
26/08/05 [26/08/05] Djeng Shih Kien [DIR] S (12,649)  0.127 81,340 27.76 -
Remarks
26/08/05 [26/08/05] Dominic Er Kong Kiong [DIR] S (12,649)  0.127 82,951 28.30 -
Remarks
26/08/05 [26/08/05] Silver Beads International Limited [SSH] S (12,649)  0.127 55,332 18.88 -
Remarks
19/08/05 [19/08/05] Djeng Shih Kien [DIR] S (700)  0.124 93,989 32.08 -
Remarks
19/08/05 [19/08/05] Dominic Er Kong Kiong [DIR] S (700)  0.124 95,600 32.62 -
Remarks
19/08/05 [19/08/05] Silver Beads International Limited [SSH] S (700)  0.124 67,981 23.20 -
Remarks
18/08/05 [18/08/05] Djeng Shih Kien [DIR] S (500)  0.120 94,689 32.32 -
Remarks
18/08/05 [18/08/05] Dominic Er Kong Kiong [DIR] S (500)  0.120 96,300 32.86 -
Remarks
18/08/05 [18/08/05] Silver Beads International Limited [SSH] S (500)  0.120 68,681 23.44 -
Remarks
17/08/05 [17/08/05] Djeng Shih Kien [DIR] S (50)  0.125 95,189 32.49 -
Remarks
17/08/05 [17/08/05] Dominic Er Kong Kiong [DIR] S (50)  0.125 96,800 33.03 -
Remarks
17/08/05 [17/08/05] Silver Beads International Limited [SSH] S (50)  0.125 69,181 23.61 -
Remarks
16/08/05 [16/08/05] Djeng Shih Kien [DIR] S (1,001)  0.125 95,239 32.51 -
Remarks
16/08/05 [16/08/05] Dr Dominic Er Kong Kiong [DIR] S (1,001)  0.125 96,850 33.05 -
Remarks
16/08/05 [16/08/05] Silver Bread International Limited [SSH] S (1,001)  0.125 69,231 23.63 -
Remarks
10/08/05 [10/08/05] Djeng Shih Kien [DIR] S (100)  0.125 96,240 32.85 -
Remarks
10/08/05 [10/08/05] Dr Dominic Er Kong Kiong [DIR] S (100)  0.125 97,851 33.39 -
Remarks
10/08/05 [10/08/05] Silver Beads International Limited [SSH] S (100)  0.125 70,232 23.97 Note
Remarks
Sales in Open Market at Own Discretion
11/07/05 [08/07/05] Lim Cheok Peng [SSH] S (14,000)  - 11,000 3.75 -
Remarks
30/04/04 [28/04/04] Khoo Ho Tong [DIR] S 400  0.100 400 NA Note
Remarks
Exercise of share options/convertibles
30/04/04 [28/04/04] Tan Boen Eng [DIR] S 400  0.100 400 NA Note
Remarks
Exercise of share options/convertibles
30/04/04 [28/04/04] Tan Suat Hua [DIR] S 1,500  0.100 1,700 0.01 Note
Remarks
Exercise of share options/convertibles
25/08/03 [15/08/03] Asia Healthcare [SSH] S (79,000)  - 79,000 NA Note
Remarks
Termination of sale and purchase agreement dated 19 June 2002 between Silver Beads International Limited and Asia Healthcare
22/08/03 [21/08/03] Dominic Er Kong Kiong [DIR] S 100  0.100 97,951 33.76 -
Remarks
19/06/02 [19/06/02] Asia Healthcare [SSH] S 70,000  0.220 79,000 27.23 -
Remarks
22/05/02 [16/05/02] RTCI [SSH] S (11,000)  0.100 5,951 2.05 -
Remarks
07/05/02 [03/05/02] RTCI [SSH] S (1,428)  0.095 16,951 5.84 -
Remarks
06/05/02 [02/05/02] RTCI [SSH] S (3,980)  0.970 18,379 6.33 -
Remarks
29/04/02 [26/04/02] RTCI [SSH] S 650  0.100 22,359 7.71 -
Remarks
22/04/02 [17/04/02] RTCI [SSH] S (481)  0.100 23,009 7.93 -
Remarks
19/04/02 [16/04/02] RTCI [SSH] S (2,250)  0.100 23,490 8.09 -
Remarks
15/04/02 [12/04/02] RTCI [SSH] S (6,000)  0.104 25,740 8.87 -
Remarks
12/04/02 [10/04/02] RTCI [SSH] S (301)  0.100 31,740 10.95 -
Remarks
11/04/02 [08/04/02] RTCI [SSH] S (846)  0.100 32,041 11.05 -
Remarks
09/04/02 [05/04/02] RTCI [SSH] S (3,050)  0.100 32,887 11.34 -
Remarks
08/04/02 [04/04/02] RTCI [SSH] S (581)  0.100 35,937 12.40 -
Remarks
04/04/02 [03/04/02] RTCI [SSH] S (1,147)  0.100 36,518 12.60 -
Remarks
25/03/02 [14/03/02 to 22/03/02] RTCI [SSH] S (25,955)  0.122-0.136 37,665 13.00 -
Remarks
26/11/00 [12/10/00] Ronnie Tan Keh Poo [SSH] S 3  0.185 256 0.09 -
Remarks
26/11/00 [09/10/00] Ronnie Tan Keh Poo [SSH] S 50  0.200 253 0.09 -
Remarks
26/11/00 [05/10/00] Ronnie Tan Keh Poo [SSH] S 50  0.209 203 0.07 -
Remarks
26/11/00 [27/09/00] Ronnie Tan Keh Poo [SSH] S 39  0.220 153 0.05 -
Remarks
* DIR - Director (include Directors of related companies)
SSH - Substantial Shareholder
COY - Company Share Buyback
TMRP - Trustee-Manager/Responsible Person
** S - Shares
W - Warrants
U - Units
R - Rights
*** Direct & Deemed Interests

Notes

  1. Only trades by directors, substantial shareholders and company share buy back are included in Insider Trades.